WeChat Mini Program
Old Version Features

Inetetamab for Injection in Combination with Vinorelbine Weekly or Every Three Weeks in HER2-positive Metastatic Breast Cancer: A Multicenter, Randomized, Phase II Clinical Trial

JOURNAL OF TRANSLATIONAL INTERNAL MEDICINE(2024)

Cited 0|Views2
Key words
metastatic breast cancer,pharmacokinetics,safety,efficacy,immunogenicity
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined